186 related articles for article (PubMed ID: 36248789)
1. Decreased peripheral basophil counts in urticaria and mouse model of oxazolone-induced hypersensitivity, the latter suggesting basopenia reflecting migration to skin.
Kishimoto I; Ma N; Takimoto-Ito R; Nakashima C; Otsuka A; Walls AF; Tanizaki H; Kambe N
Front Immunol; 2022; 13():1014924. PubMed ID: 36248789
[TBL] [Abstract][Full Text] [Related]
2. Response of peripheral blood basophils in subjects with chronic spontaneous urticaria during treatment with omalizumab.
MacGlashan D; Saini S; Schroeder JT
J Allergy Clin Immunol; 2021 Jun; 147(6):2295-2304.e12. PubMed ID: 33716077
[TBL] [Abstract][Full Text] [Related]
3. Eosinopenia, in Chronic Spontaneous Urticaria, Is Associated with High Disease Activity, Autoimmunity, and Poor Response to Treatment.
Kolkhir P; Church MK; Altrichter S; Skov PS; Hawro T; Frischbutter S; Metz M; Maurer M
J Allergy Clin Immunol Pract; 2020 Jan; 8(1):318-325.e5. PubMed ID: 31472293
[TBL] [Abstract][Full Text] [Related]
4. Improved FcεRI-Mediated CD203c Basophil Responsiveness Reflects Rapid Responses to Omalizumab in Chronic Spontaneous Urticaria.
Oda Y; Fukunaga A; Washio K; Imamura S; Mizuno M; Hatakeyama M; Ogura K; Nishigori C
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1166-1176.e8. PubMed ID: 32898709
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes.
Johal KJ; Chichester KL; Oliver ET; Devine KC; Bieneman AP; Schroeder JT; MacGlashan DW; Saini SS
J Allergy Clin Immunol; 2021 Jun; 147(6):2271-2280.e8. PubMed ID: 33713769
[TBL] [Abstract][Full Text] [Related]
6. Urticaria and basophils.
Saini SS
Allergol Int; 2023 Jul; 72(3):369-374. PubMed ID: 37221123
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to serum histamine releasing activity.
Grattan CE; Walpole D; Francis DM; Niimi N; Dootson G; Edler S; Corbett MF; Barr RM
Clin Exp Allergy; 1997 Dec; 27(12):1417-24. PubMed ID: 9433937
[TBL] [Abstract][Full Text] [Related]
8. Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity.
Grattan CE; Dawn G; Gibbs S; Francis DM
Clin Exp Allergy; 2003 Mar; 33(3):337-41. PubMed ID: 12614448
[TBL] [Abstract][Full Text] [Related]
9. Interval shifts in basophil measures correlate with disease activity in chronic spontaneous urticaria.
Oliver ET; Sterba PM; Saini SS
Allergy; 2015 May; 70(5):601-3. PubMed ID: 25631394
[TBL] [Abstract][Full Text] [Related]
10. Higher House Dust Mite-Specific IgE Levels among Chronic Spontaneous Urticaria Patients May Implicate Higher Basophil Reactivity.
Liang G; Zhou J; Jiang L; Wang W; Wu Q; Gao C; Liu W; Li S; Feng S; Song Z
Int Arch Allergy Immunol; 2023; 184(11):1126-1134. PubMed ID: 37604140
[TBL] [Abstract][Full Text] [Related]
11. Hematologic parameters as biomarkers for antihistamine and omalizumab resistance in chronic spontaneous urticaria.
Magen E; Waitman DA; Kahan NR
Allergy Asthma Proc; 2021 Jan; 42(1):e17-e24. PubMed ID: 33404397
[No Abstract] [Full Text] [Related]
12. Upregulated expression of substance P in basophils of the patients with chronic spontaneous urticaria: induction of histamine release and basophil accumulation by substance P.
Zheng W; Wang J; Zhu W; Xu C; He S
Cell Biol Toxicol; 2016 Jun; 32(3):217-28. PubMed ID: 27147256
[TBL] [Abstract][Full Text] [Related]
13. Positive Basophil Tests Are Linked to High Disease Activity and Other Features of Autoimmune Chronic Spontaneous Urticaria: A Systematic Review.
Moñino-Romero S; Hackler Y; Okas TL; Grekowitz EM; Fluhr JW; Hultsch V; Kiefer LA; Pyatilova P; Terhorst-Molawi D; Xiang YK; Siebenhaar F; Maurer M; Kolkhir P
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2411-2416. PubMed ID: 37286132
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin.
Metz M; Staubach P; Bauer A; Brehler R; Gericke J; Kangas M; Ashton-Chess J; Jarvis P; Georgiou P; Canvin J; Hillenbrand R; Erpenbeck VJ; Maurer M
Theranostics; 2017; 7(5):1266-1276. PubMed ID: 28435464
[No Abstract] [Full Text] [Related]
15. Basophil CD63 expression in chronic spontaneous urticaria: correlation with allergic sensitization, serum autoreactivity and basophil reactivity.
Chen Q; Zhai Z; Xu J; Chen W; Chen S; Zhong H; Huang X; Hao F; Song Z
J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):463-468. PubMed ID: 27518369
[TBL] [Abstract][Full Text] [Related]
16. Omalizumab may not inhibit mast cell and basophil activation in vitro.
Gericke J; Ohanyan T; Church MK; Maurer M; Metz M
J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1832-6. PubMed ID: 25257818
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.
Kaplan AP; Giménez-Arnau AM; Saini SS
Allergy; 2017 Apr; 72(4):519-533. PubMed ID: 27861988
[TBL] [Abstract][Full Text] [Related]
18. IgE receptor responsiveness of basophils in chronic inducible urticaria.
Mizuno M; Oda Y; Imamura S; Washio K; Fukumoto T; Fukunaga A
Front Immunol; 2022; 13():995596. PubMed ID: 36211415
[TBL] [Abstract][Full Text] [Related]
19. Response of FcεRI-bearing leucocytes to omalizumab in chronic spontaneous urticaria.
Alizadeh Aghdam M; Knol EF; van den Elzen M; den Hartog Jager C; van Os-Medendorp H; Knulst AC; Otten HG; Röckmann H
Clin Exp Allergy; 2020 Mar; 50(3):364-371. PubMed ID: 31925825
[TBL] [Abstract][Full Text] [Related]
20. Correlations between disease activity, autoimmunity and biological parameters in patients with chronic spontaneous urticaria.
de Montjoye L; Darrigade AS; Giménez-Arnau A; Herman A; Dumoutier L; Baeck M
Eur Ann Allergy Clin Immunol; 2021 Mar; 53(2):55-66. PubMed ID: 31965967
[No Abstract] [Full Text] [Related]
[Next] [New Search]
